Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
7.53
+0.01 (0.13%)
Jan 8, 2026, 1:37 PM EST - Market open
Lipocine Market Cap
Lipocine has a market cap or net worth of $41.81 million as of January 8, 2026. Its market cap has increased by 67.22% in one year.
Market Cap
41.81M
Enterprise Value
26.86M
1-Year Change
67.22%
Ranking
Category
Stock Price
$7.53
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $41.81M, a decrease of -49.20%. That is a compound annual growth rate of -5.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 41.80M | -6.28% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.89B |
| Johnson & Johnson | 488.99B |
| AbbVie | 387.55B |
| UnitedHealth Group | 311.68B |
| AstraZeneca | 280.48B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.86B |
| Novo Nordisk | 241.55B |